Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

598
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
598
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

354
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

639
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
639
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient Hemichorea Associated With Mitochondrial Metabolic Stroke.

Journal of child neurology·2026
Same author

Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients.

Brain : a journal of neurology·2025
Same author

Two tales of therapeutic innovations for Leigh syndrome spectrum.

Journal of neurogenetics·2025
Same author

Translating Genetic Discovery into a Mechanistic Understanding of Pediatric Movement Disorders: Lessons from Genetic Dystonias and Related Disorders.

Advanced genetics (Hoboken, N.J.)·2023
Same author

The nuances of immunotherapy for NORSE/FIRES.

Epilepsia·2022
Same author

Role of Ketogenic Diets in Multiple Sclerosis and Related Animal Models: An Updated Review.

Advances in nutrition (Bethesda, Md.)·2022

Related Experiment Video

Updated: Mar 17, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K

Rethinking Corticosteroid Therapy in Pediatric Neurology.

Wei-Sheng Lin1,2

  • 1Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan.

Journal of Inflammation Research
|March 16, 2026
PubMed
Summary
This summary is machine-generated.

Corticosteroids are vital for pediatric neurological disorders but may worsen neuroinflammation. New targeted therapies and careful risk-benefit analysis are crucial for optimizing their use.

Keywords:
corticosteroidsglucocorticoid receptor modulatorglucocorticoid toxicityintra-erythrocyte drug deliveryneuroinflammationvamorolone

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

2.1K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 17, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

2.1K
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.1K

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Pharmacology

Background:

  • Corticosteroids are a primary treatment for pediatric neurological conditions.
  • Concerns exist regarding their broad immunomodulatory effects and potential to exacerbate neuroinflammation in the context of precision medicine.
  • Reappraisal of their role is necessary, considering disease-specific immunopathogenesis.

Purpose of the Study:

  • To critically re-evaluate the role of corticosteroids in pediatric neurology.
  • To explore the potential for corticosteroids to potentiate innate immune responses and neuroinflammation.
  • To discuss emerging therapeutic innovations and their safety profiles.

Main Methods:

  • Review of existing literature on corticosteroid use in pediatric neurological disorders.
  • Analysis of immunomodulatory effects and potential adverse events.
  • Examination of novel therapeutic strategies and their clinical evidence.

Main Results:

  • Corticosteroids may exacerbate neuroinflammation by potentiating innate immune responses.
  • Long-term use necessitates careful risk-benefit analysis due to potential adverse effects.
  • Innovations like selective glucocorticoid receptor modulators and novel drug delivery systems show promise.
  • Evidence suggests corticosteroid benefit in drug-resistant epilepsies beyond infantile epileptic spasms syndrome.

Conclusions:

  • Disease-specific immunopathogenesis should guide therapeutic decisions involving corticosteroids.
  • Further research is needed to optimize corticosteroid dosing, formulation, timing, and administration routes for various pediatric neurological disorders.
  • Balancing efficacy with safety concerns is paramount in corticosteroid management.